Overview

Study of Oral Edaravone in Healthy Adult Males

Status:
Completed
Trial end date:
2018-08-03
Target enrollment:
Participant gender:
Summary
To evaluate the pharmacokinetics safety, and tolerability of single and multiple doses of edaravone solution and suspension in healthy adult males
Phase:
Phase 1
Details
Lead Sponsor:
Mitsubishi Tanabe Pharma Corporation
Treatments:
Edaravone